Clinical impact of early brain atrophy in clinically isolated syndromes

Multiple Sclerosis Journal

Volumn 19, Issue 14, 2013, Pages 1878-1886

  Perez Miralles F ^a,b   Sastre Garriga, J ^a   Tintore M ^a   Arrambide, G ^a   Nos, C ^a   Perkal, H ^a   Rio J ^a   Edo, M C ^a   Horga, A ^a   Castillo J ^a   Auger, C ^a   Huerga, E ^a   Rovira, A ^a   Montalban, X ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Brain atrophy; brain volume; clinically isolated syndrome; disability; grey matter; magnetic resonance imaging; multiple sclerosis

Indexed keywords

CORTICOSTEROID;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN MAPPING; BRAIN SIZE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAY MATTER; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MCDONALD CRITERIA; MULTIPLE SCLEROSIS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PROSPECTIVE STUDY; TISSUE SPECIFICITY; WHITE MATTER;

BRAIN ATROPHY; BRAIN VOLUME; CLINICALLY ISOLATED SYNDROME; DISABILITY; GREY MATTER; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS;

ADRENAL CORTEX HORMONES; ADULT; ATROPHY; BRAIN; DEMYELINATING DISEASES; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; ORGAN SIZE; PROSPECTIVE STUDIES; RECURRENCE; TIME FACTORS; YOUNG ADULT;

EID: 84888623258     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513488231     Document Type: Article

References (30)

1. Bjartmar C, Trapp BD. Axonal and neuronal degeneration in multiple sclerosis: Mechanisms and functional consequences. Curr Opin Neurol. 2001 ; 14: 271-278
2. Miller DH, Barkhof F, Frank JA, et al. Measurement of atrophy in multiple sclerosis: Pathological basis, methodological aspects and clinical relevance. Brain. 2002 ; 125: 1676-1695
3. Dalton CM, Chard DT, Davies GR, et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain. 2004 ; 127: 1101-1107
4. Sastre-Garriga J, Ingle GT, Chard DT, et al. Grey and white matter changes in early primary progressive multiple sclerosis: A longitudinal study. Brain. 2005 ; 128: 1454-1460
5. Rudick RA, Lee JC, Nakamura K, et al. Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS. J Neurol Sci. 2009 ; 282: 106-111
6. Calabrese M, Rinaldi F, Mattisi I, et al. The predictive value of gray matter atrophy in clinically isolated syndromes. Neurology. 2011 ; 77: 257-263
7. Di Filippo, Anderson VM, Altmann DR, et al. Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry. 2010 ; 81: 204-208
8. Raz E, Cercignami M, Sbardella E, et al. Gray- and white-matter changes 1 year after first clinical episode of multiple sclerosis: MR imaging. Radiology. 2010 ; 257: 448-454
9. Kalincik T, Vaneckova M, Tyblova M, et al. Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: A longitudinal cohort study. PLoS One. 2012 ; 7: e50101
10. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 Revisions to the "McDonald Criteria.". Ann Neurol. 2005 ; 58: 840-846
11. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology. 1983 ; 33: 1444-1452
12. Woolrich MW, Jbabdi S, Patenaude B, et al. Bayesian analysis of neuroimaging data in FSL. Neuroimage. 2009 ; 45: S173-186
13. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 2004 ; 23: S208-219
14. Perneger TV. What's wrong with Bonferroni adjustments. BMJ. 1998 ; 316: 1236-1238
15. Chard DT, Griffin CM, Parker GJM, et al. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain. 2002 ; 125: 327-337
16. Sastre-Garriga J, Ingle GT, Chard DT, et al. Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis. Neuroimage. 2004 ; 22: 353-359
17. Fisher E, Lee JC, Nakamura K, et al. Gray matter atrophy in multiple sclerosis: A longitudinal study. Ann Neurol. 2008 ; 64: 255-265
18. Fisniku LK, Chard DT, Jackson JS, et al. Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol. 2008 ; 64: 247-254
19. Calabrese M, Atzori M, Bernardi V, et al. Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol. 2007 ; 254: 1212-1220
20. Raz E, Cercignami M, Sbardella E, et al. Clinically isolated syndrome suggestive of multiple sclerosis: Voxelwise regional investigation of white and gray matter. Radiology. 2010 ; 254: 227-234
21. Raz N, Rodrigue KM. Differential aging of the brain: Patterns, cognitive correlates and modifiers. Neurosci Biobehav Rev. 2006 ; 30: 730-748
22. Courchesne E, Chisum HJ, Townsend J, et al. Normal brain development and aging: Quantitative analysis at in vivo MR imaging in healthy volunteers. Radiology. 2000 ; 216: 672-682
23. Ge Y, Grossman RI, Babb JS, et al. Age-related total gray matter and white matter changes in normal adult brain. Part I: Volumetric MR imaging analysis. Am J Neuroradiol. 2002 ; 23: 1327-1333
24. Horakova D, Dwyer MG, Havrdova E, et al. Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis. A 5-year longitudinal study. J Neurol Sci. 2009 ; 282: 112-119
25. Roosendaal SD, Bendfeldt K, Vrenken H, et al. Grey matter volume in a large cohort of MS patients: Relation to MRI parameters and disability. Mult Scler. 2011 ; 17: 1098-1106
26. Sierra-Marcos A, Mitjana R, Castilló J, et al. Demyelinating lesions as incidental findings in magnetic resonance imaging. A study of 11 cases with clinico-radiological follow-up and a review of the literature. Rev Neurol. 2010 ; 51: 129-134
27. Tintoré M, Rovira A, Río J, et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?. Neurology. 2008 ; 70: 1079-1083
28. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions of the McDonald criteria. Ann Neurol. 2011 ; 69: 292-302
29. Battaglini M, Jenkinson M, De Stefano N. Evaluating and reducing the impact of white matter lesions on brain volume measurements. Hum Brain Mapp. 2012 ; 33: 2062-2071
30. Vrenken H, Jenkinson M, Horsfield MA, et al. Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis. J Neurol.: